Genmab A/S (GMAB)

Genmab Income Statement

Financials in millions DKK. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	17,763	16,474	14,505	8,417	10,111	5,366
Revenue Growth (YoY)	16.71%	13.57%	72.33%	-16.75%	88.43%	77.39%
Cost of Revenue	411	226	0	0	0	0
Gross Profit	17,352	16,248	14,505	8,417	10,111	5,366
Selling, General & Admin	3,478	3,297	2,676	1,283	661	342
Research & Development	8,189	7,630	5,562	4,181	3,137	2,386
Operating Expenses	11,667	10,927	8,238	5,464	3,798	2,728
Operating Income	5,685	5,321	6,267	2,953	6,313	2,638
Interest Expense / Income	992	942	680	702	1,558	7
Other Expense / Income	-2,374	-1,258	-1,358	-1,667	-1,149	-228
Pretax Income	7,067	5,637	6,945	3,918	5,904	2,859
Income Tax	1,616	1,285	1,493	961	1,146	693
Net Income	5,451	4,352	5,452	2,957	4,758	2,166
Net Income Growth	4.89%	-20.18%	84.38%	-37.85%	119.67%	47.15%
Shares Outstanding (Basic)	66	66	66	66	65	64
Shares Change	0.17%	0.36%	0.32%	0.84%	1.20%	-
EPS (Basic)	8.35	6.66	8.34	4.52	7.30	3.44
EPS (Diluted)	8.28	6.60	8.26	4.48	7.22	3.40
EPS Growth	5.08%	-20.06%	84.48%	-38.00%	112.20%	43.40%
Free Cash Flow	5,358	7,004	3,595	1,976	6,126	1,215
Free Cash Flow Per Share	8.11	10.60	5.46	3.01	9.41	1.89
Gross Margin	97.69%	98.63%	100.00%	100.00%	100.00%	100.00%
Operating Margin	32.00%	32.30%	43.21%	35.08%	62.44%	49.16%
Profit Margin	30.69%	26.42%	37.59%	35.13%	47.06%	40.37%
Free Cash Flow Margin	30.16%	42.52%	24.78%	23.48%	60.59%	22.64%
Effective Tax Rate	22.87%	22.80%	21.50%	24.53%	19.41%	24.24%
EBITDA	-	-	-	-	-	2,866
EBITDA Margin	-	-	-	-	-	53.41%
EBIT	8,059	6,579	7,625	4,620	7,462	2,866
EBIT Margin	45.37%	39.94%	52.57%	54.89%	73.80%	53.41%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).